Uncommon Cents Investing’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.29M Buy
5,920
+55
+0.9% +$20.4K 0.5% 69
2026
Q1
$1.72M Buy
5,865
+1,350
+30% +$444K 0.4% 76
2025
Q4
$1.58M Buy
4,515
+155
+4% +$52.4K 0.38% 77
2025
Q3
$1.41M Buy
4,360
+200
+5% +$62.2K 0.35% 84
2025
Q2
$1.62M Buy
4,160
+465
+13% +$187K 0.43% 77
2025
Q1
$1.61M Buy
3,695
+5
+0.1% +$2.01K 0.47% 70
2024
Q4
$1.36M Sell
3,690
-5
-0.1% -$2.09K 0.41% 80
2024
Q3
$1.92M Buy
3,695
+47
+1% +$25.1K 0.54% 58
2024
Q2
$1.98M Buy
3,648
+50
+1% +$26.4K 0.62% 53
2024
Q1
$1.87M Buy
3,598
+48
+1% +$23.9K 0.57% 55
2023
Q4
$1.67M Sell
3,550
-60
-2% -$27.7K 0.55% 58
2023
Q3
$1.57M Sell
3,610
-40
-1% -$18.1K 0.58% 60
2023
Q2
$1.62M Sell
3,650
-20
-0.5% -$9.23K 0.57% 59
2023
Q1
$1.69M Sell
3,670
-5
-0.1% -$2.38K 0.62% 57
2022
Q4
$1.88M Buy
3,675
+235
+7% +$119K 0.69% 49
2022
Q3
$1.56M Buy
3,440
+1,840
+115% +$880K 0.66% 52
2022
Q2
$772K Buy
1,600
+1,075
+205% +$532K 0.31% 94
2022
Q1
$258K Buy
+525
New +$240K 0.09% 134

Other funds holding ELV

Uncommon Cents Investing's ELV Position: Q2 2026 in Review

Uncommon Cents Investing increased its Elevance Health (ELV) stake by 0.94% in Q2 2026, buying an estimated $20.4K and bringing the position to 5,920 shares worth $2.29M. The position accounts for 0.5% of the portfolio, ranked #69.

Uncommon Cents Investing first reported a position in ELV in Q1 2022 and has held it in 18 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Uncommon Cents Investing held 5,920 shares of Elevance Health worth $2.29M as of Q2 2026.
  • Uncommon Cents Investing bought 55 Elevance Health shares in Q2 2026, an estimated $20.4K.
  • Elevance Health made up 0.5% of Uncommon Cents Investing's portfolio in Q2 2026, its #69 holding.
  • Uncommon Cents Investing first reported a position in Elevance Health in Q1 2022 and has held it in 18 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Uncommon Cents Investing's 13F filing for Q2 2026, filed 20 Jul 2026.